In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback